A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis

Area of Science:

• Cardiology
• Pharmacology
• Inflammation Research

Background:

• Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are crucial for reducing cardiovascular morbidity and mortality.
• Emerging evidence highlights inflammation's role in atherosclerosis, prompting research into high-dose statin therapy.
• Statins exhibit anti-inflammatory and antioxidant properties independent of their lipid-lowering effects.

Purpose of the Study:

• To review recent large-scale randomized trials of high-dose statin therapy.
• To evaluate the impact of aggressive lipid lowering on cardiovascular outcomes.
• To discuss the anti-inflammatory effects of high-dose statins, particularly on C-reactive protein.

Main Methods:

• Overview of recent, large-scale, randomized, placebo-controlled, and active-controlled trials.
• Analysis of data from trials involving stable and unstable coronary artery disease.
• Inclusion of studies on percutaneous coronary intervention outcomes.

Main Results:

• High-dose statin therapy has demonstrated significant reductions in cardiovascular events.
• Evidence suggests potent anti-inflammatory effects of high-dose statins.
• Reductions in C-reactive protein levels are observed with high-dose statin use.

Conclusions:

• High-dose statin therapy is effective in managing cardiovascular disease.
• The anti-inflammatory actions of statins contribute to their cardiovascular benefits.
• Further research confirms the pleiotropic effects of statins beyond lipid modification.